JAK inhibition in inflammatory bowel disease

Olivera, P; Danese, S; Peyrin-Biroulet, L

Peyrin-Biroulet, L (reprint author), Univ Lorraine, Nancy Univ Hosp, INSERM, U954, Allee Morvan, F-54511 Vandoeuvre Les Nancy, France.; Peyrin-Biroulet, L (reprint author), Univ Lorraine, Nancy Univ Hosp, Dept Hepatogastroenterol, Allee Morvan, F-54511 Va

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017; 13 (7): 693

Abstract

Introduction: Current available treatments for inflammatory bowel disease (IBD) have some limitations and new options are needed. Several new molecule......

Full Text Link